
The lack of clinical trials represents a bottleneck in the future of the German health care zzso Although central organizations as the zzso zzso Joint zzso the zzso zzso for Quality and Efficiency in Health zzso or the zzso zzso for Hospital zzso which were established during the last years as central boards for the decision process in health care, use the results of high-quality trials as basis of their decisions, the zzso use as an implicit way of clinical trial promotion by German sickness funds to reduce the cost of care in this special setting has at the same time been zzso in recent zzso an important basis for the development of zzso therapies through clinical studies was abolished and completely zzso Also, the underlying conditions of zzso clinical trials caused more effort because of new zzso The trend of zzso in the German health care system based on short resources and the use of zzso evidence for decision-making must lead to the establishment of a new and effective financing and funding of clinical zzso zzso funds must also be involved in this zzso zzso and zzso who are zzso of the quality and sponsoring of zzso clinical trials, must in conclusion zzso basic conditions for successful financing and funding of clinical trials in consideration of their duties and zzso 

